CommercialNovember 1, 2022

November 2022 Newsletter

Administrative

AdministrativeCommercialOctober 31, 2022

Support documentation for AIM prior authorization requests

AdministrativeCommercialOctober 31, 2022

Mail is being forwarded to new post office box addresses for one year

AdministrativeCommercialOctober 31, 2022

CAA: Keep your provider directory information up to date

Policy Updates

Medical Policy & Clinical GuidelinesCommercialOctober 31, 2022

Medical Policy and Clinical Guideline updates
Material Adverse Change (MAC)

Reimbursement PoliciesCommercialOctober 31, 2022

Correction to reimbursement policy: Place of Service (Facility)
Material Adverse Change (MAC)

Products & Programs

PharmacyCommercialOctober 31, 2022

Specialty pharmacy updates - November 2022
Material Adverse Change (MAC)

State & Federal

State & FederalMedicaidOctober 31, 2022

Important information about utilization management

State & FederalMedicaidOctober 31, 2022

Antipsychotic medications and diabetes

State & FederalMedicaidOctober 31, 2022

Alcohol use disorders often coexist with psychiatric disorders

State & FederalMedicaidOctober 31, 2022

Keep up with Medicaid news - November 2022
View these Medicaid articles:
  • Medical drug benefit Clinical Criteria updates
  • Prior authorization requirement changes effective November 1, 2022

State & FederalMedicare AdvantageOctober 31, 2022

Keep up with Medicare news - November 2022
View these Medicare articles:
  • Medical drug benefit Clinical Criteria updates
  • New specialty pharmacy medical step therapy requirements (Avastin, Mvasi)
  • New specialty pharmacy medical step therapy requirements (Zarxio)